Psoriasis Nanomedicine Hydrogel
Psoriasis Nanomedicine Hydrogel is a scientifically advanced formulation designed to deliver fast, focused relief for psoriasis-affected skin. Powered by nanotechnology, this hydrogel allows active therapeutic agents to penetrate deeply into the skin, targeting inflammation at the cellular level for more effective and sustained healing.
Type: Topical therapeutic hydrogel
Target: Mild-to-moderate plaque psoriasis
Target Users:
- Dermatologists, hospitals, and clinics
- Patients seeking safe and long-term psoriasis management
Product Stage
Research & Development
Currently undergoing formulation and lab testing
Clinical Trials
In testing phase for safety and efficacy
Regulatory Review
Awaiting approval from health authorities
Market Launch
Newly released and available for purchase
Key Features
Patented eugenol-loaded lipid nanoparticle hydrogel
Sustained and Controlled drug release up to 48 hours
Enhanced skin penetration and bioavailability
Non-steroidal, plant-based, FDA-approved excipients
Minimizes side effects like skin thinning, burning, or immune suppression
Market Entry
Prescription segment via dermatology specialists
Supported by GLP studies and an IND filing
